Conversion rate of tuberculosis screening tests among dermatology patients treated with tumor necrosis factor inhibitors

Background: The use of tumor necrosis factor-α inhibitors (TNFi) has been associated with an increased risk latent tuberculosis (TB) reactivation. The role of TB screening assays in monitoring patients during TNFi therapy remains uncertain. Spontaneous conversions and reversions have been described....

Full description

Bibliographic Details
Main Authors: Sarah F Alsukait, Alaa B Alsaad, Ghadah F Alotaibi, Fahad M Alsaif, Hend M Alotaibi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Dermatology
Subjects:
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2022;volume=67;issue=1;spage=1;epage=4;aulast=Alsukait